InsidersTradesSigma
Total declarations
Companies
▲ Purchases (19 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
19
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Sirgo Mark A, Director. Director active across 2 companies, notably Biodelivery Sciences International INC. In total, 30 filings have been logged. Split: 19 buys · 2 sells. Total volume traded: €790k. Activity tracked since 11 May 2021. The latest transaction was disclosed on 1 July 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations30 total
7,885 sharesCommon StockSEC:0001578563-23-000014:0
175,000 shares@ US$0.24558.1% of flowCommon stockSEC:0001551986-22-000074:0
175,000 shares@ US$0.24558.1% of flowCommon stockSEC:0001551986-22-000067:0
Ideal exit: 28 Mar 2023 (T+270)
106,383 shares@ US$0.4711.2% of flowCommon StockSEC:0001578563-22-000016:0
Ideal exit: 12 Feb 2023 (T+270)
1,166,866 shares0Common StockSEC:0001103021-22-000071:0
86,449.55 shares@ US$0.578410.6% of flowCommon stockSEC:0001551986-22-000023:0
Ideal exit: 28 Nov 2022 (T+270)
7,684 shares0Common StockSEC:0001103021-22-000023
7,684 shares0Common StockSEC:0001103021-22-000023:0
18,587 shares@ US$2.6927.3% of flowCommon StockSEC:0001103021-21-000124
Ideal exit: 29 Aug 2022 (T+270)
18,587 shares@ US$2.6913.6% of flowCommon StockSEC:0001103021-21-000124:0
Ideal exit: 29 Aug 2022 (T+270)
50,000 shares@ US$0.8923.7% of flowCommon StockSEC:0001578563-21-000044
Ideal exit: 29 Aug 2022 (T+270)
50,000 shares@ US$0.899.3% of flowCommon StockSEC:0001578563-21-000044:0
Ideal exit: 29 Aug 2022 (T+270)
20,000 shares@ US$1.064.4% of flowCommon stockSEC:0001551986-21-000122:0
Ideal exit: 15 Aug 2022 (T+270)
20,000 shares@ US$1.0611.3% of flowCommon stockSEC:0001551986-21-000122
Ideal exit: 15 Aug 2022 (T+270)
10,000 shares@ US$3.0416.6% of flowCommon StockSEC:0001103021-21-000116
10,000 shares@ US$3.0416.6% of flowCommon StockSEC:0001103021-21-000118
Ideal exit: 15 Aug 2022 (T+270)
10,000 shares@ US$3.048.3% of flowCommon StockSEC:0001103021-21-000118:0
Ideal exit: 15 Aug 2022 (T+270)
10,000 shares@ US$3.048.3% of flowCommon StockSEC:0001103021-21-000116:0
16,000 shares@ US$3.2013.8% of flowCommon StockSEC:0001103021-21-000112:0
Ideal exit: 8 Aug 2022 (T+270)
16,000 shares@ US$3.2027.5% of flowCommon StockSEC:0001103021-21-000112
Ideal exit: 8 Aug 2022 (T+270)
73,529 shares@ US$1.3619.9% of flowCommon stockSEC:0001551986-21-000101:0
Ideal exit: 4 Jun 2022 (T+270)
73,529 shares@ US$1.3616.7% of flowCommon stockSEC:0001551986-21-000101
Ideal exit: 4 Jun 2022 (T+270)
4,000 shares0Common StockSEC:0001103021-21-000082:0
4,000 shares0Common StockSEC:0001103021-21-000082
25,000 shares@ US$1.105.5% of flowCommon stockSEC:0001551986-21-000097:0
Ideal exit: 17 May 2022 (T+270)
25 of 30 declarations
About Sirgo Mark A
Mark A Sirgo is an executive at BIODELIVERY SCIENCES INTERNATIONAL INC.
